MLB

MLB drops suit against Biogenesis, owner Bosch

{eot}
The Canadian Press
2/19/2014 5:40:24 PM
Decrease Text SizeIncrease Text Size
Text Size

MIAMI - Major League Baseball has withdrawn its lawsuit against a defunct Florida anti-aging clinic at the centre of the scandal involving use of banned substances by players, including New York Yankees star Alex Rodriguez.

A lawyer for MLB, Matthew Menchel, confirmed Wednesday the league dropped its case against Biogenesis of America, its owner Anthony Bosch and several other individuals. The lawsuit had accused Biogenesis and Bosch of conspiring with players to violate their contracts by providing them with banned performance-enhancing substances.

Fourteen players associated with the Coral Gables clinic were disciplined last year by MLB, including a season-long 2014 suspension imposed on Rodriguez. The Yankees star recently dropped his lawsuit against MLB and agreed to serve the suspension.

Although the lawsuit sought unspecified money damages, it also provided MLB a way to subpoena clinic records.

Spring Training Baseballs (Photo: The Canadian Press)

zoom

(Photo: The Canadian Press)
Share This

Share This

Add to FacebookAdd to DiggAdd to FarkAdd to TwitterAdd to Stumble UponAdd to Reddit
Print this Story



Baseball Canada

Keep up with the latest on Canada's national programs from the governing body for amateur baseball in Canada.


Baseball Canada Website

Podcasts

TSN 1050: The Baseball Podcast : Episode 17 - Aug. 6th

Scott MacArthur, Richard Griffin & Gregor Chisholm discuss quiet trade deadline for the Blue Jays, struggling rotation & potential Biogenesis fallout.

TSN 1050: The Baseball Podcast: July 30 - Episode 15

Scott MacArthur & Toronto Star's Richard Griffin preview the trade deadline, Blue Jays' needs & being on Boston as Jon Lester rumours ramp up.

TSN 1050: Blue Lunch: July 9 - John McDonald

LA Angels infielder, John McDonald joined Blue Lunch to discuss his career from the time he left Toronto to the present.


More Podcasts

© 2014
All rights reserved.
Bell Media Television